Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 42, Issue 3, 2004, Pages 1030-1034

  Bemer, Pascale ^a   Bodmer, Thomas ^b   Munzinger, Juerg ^c   Perrin, Monique ^d   Vincent, Véronique ^e   Drugeon, Henri ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF BERN   (Switzerland)

^c LUZERNER KANTONSSPITAL   (Switzerland)

^d Hopital Bel Air CHR Metz   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; EVALUATION; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VALIDATION PROCESS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 1542409131     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.3.1030-1034.2004     Document Type: Article

References (20)

1. Aono, A., K. Hirano, S. Hamasaki, and C. Abe. 2002. Evaluation of BACTEC MGIT 960 pyrazinamide medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (pyrazinamide): compared with the results of pyrazinamidase assay and Kyokuto pyrazinamide test. Diagn. Microbiol. Infect. Dis. 44:347-352.
2. Berner, P., F. Palicova, S. Rüsch-Gerdes, H. B. Drugeon, and G. Pfyffer. 2002. Multicenter evaluation of fully automated BACTEC mycobacteria growth indicator tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:150-154.
3. Bergmann, J. S., and G. L. Woods. 1997. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin. Diagn. Microbiol. Infect. Dis. 28:153-156.
4. Bergmann, J. S., and G. L. Woods. 1998. Evaluation of the ESP Culture System II for testing susceptibilities of Mycobacterium tuberculosis to four primary antituberculous drugs. J. Clin. Microbiol. 36:2940-2943.
5. Brunello, F., and R. Fontana. 2000. Reliability of the MB/BACT System for testing susceptibility of Mycobacterium tuberculosis complex strains to anti-tuberculous drugs. J. Clin. Microbiol. 38:872-873.
6. Diaz-Infantes, M. S., M. J. Ruiz-Serrano, L. Martinez-Sanchez, A. Ortega, and E. Bouza. 2000. Evaluation of the MB/BACT Mycobactenum detection system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 38:1988-1989.
7. Inderlied, C. B., and K. A. Nash. 1996. Antimycobacterial agents, p. 127-176. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, Md.
8. LaBombardi, V. J. 2002. Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide. J. Clin. Microbiol. 40:2238-2239.
9. Laszlo, A., M. Rahman, M. Raviglione, F. Bustreo, and the WHO/IUATLD Network of Supranational Reference Laboratories. 1997. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int. J. Tuberc. Lung Dis. 1:231-238.
10. Laszlo, A., M. Rahman, M. Espinal, M. Raviglione, and the WHO/IUATLD Network of Supranational Reference Laboratories. 2002. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: five rounds of proficiency testing, 1994-1998. Int. J. Tuberc. Lung Dis. 6:748-756.
11. Macondo E. A., F. Ba, A. Gaye-Diallo, N. C. Toure-Kane, O. Kaire, A. Gueye-Ndiaye, C. S. Boye, and S. Mboup. 2000. Rapid susceptibility testing of Mycobacterium tuberculosis by the mycobacteria growth indicator tube (MGIT antimycobacterial susceptibility testing SIRE). Clin. Microbiol. Infect. 6:363-367.
12. Pfyffer, G. E., F. Palicova, and S. Rüsch-Gerdes. 2002. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 System. J. Clin. Microbiol. 40:1670-1674.
13. Robert, G. D., N. L. Goodman, L. Heifets, H. W. Larsh, T. H. Lindner, J. K. McClatchy, M. R. McGinnis, S. H. Siddiqi, and P. Wright. 1983. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18:689-696.
14. Rüch-Gerdes, S., C. Domehl, G. Nardi, M. R. Gismondo, H.-M. Welscher, and G. E. Pfyffer. 1999. Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J. Clin. Microbiol. 37:45-48.
15. Siddiqi, S. H. 1995. BACTEC 460 TB System. Product and procedure manual, revision D. Becton Dickinson Microbiology Systems, Sparks, Md.
16. Tenover, F. C., J. T. Crawford, R. E. Huebner, L. J. Geiter, C. R. Horsburgh, Jr., and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.
17. Tortoli, E., R. Mattei, A. Savarino, L. Bartolini, and J. Beer. 2000. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BACT (Organon Teknika) Systems. Diagn. Microbiol. Infect. Dis. 38:83-86.
18. Tortoli, E., M. Benedetti, A. Fontanelli, and M. T. Simonetti. 2002. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J. Clin. Microbiol. 40:607-610.
19. World Health Organization. 1997. Antituberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1994-1997. WHO/TB/97.229. World Health Organization, Geneva, Switzerland.
20. Yew, W. W., S. C. Wa Tong, K. S. Lui, S. K. Fai Leung, C. H. Chau, and E. P. Wang. 2001. Comparison of MB/BACT System and agar proportion method in drug susceptibility testing of Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis, 39:229-232.